Here’s a blog about the new GS1 Standard for Clinical Trials and how we can help you adopt it Read More
Changing regulations, such as Annex VI clinical trial regulation, need to be incorporated into the label and artwork processes in time for when the regulation takes effect.
Read More
PRISYM ID will be exhibiting and hosting a workshop at this year’s American Medical Device Summit on October 28-29, 2019.
Read More
PRISYM ID will be attending this years RAPS Regulatory Convergence on September, 22-24 2019 in Philadelphia.
Read More
The imminence of Annex VI will have a resounding impact upon the clinical trial industry, adding further complexity to the existing compliance legislation. Read More
Annex VI EU No 536/2014 is a clinical trial regulation which will impose new labeling challenges to the industry. Read More
PRISYM ID will be presenting at this year’s MedTech Intelligence, Virtual Conference on 23rd and 24th May 2019.
Read More
PRISYM ID are proudly exhibiting at 3rd Annual EU MDR Implementation Conference.
Read More
PRISYM ID will be presenting at this year’s MedTech Intelligence, Virtual Conference on 23rd and 24th May 2019.
Read More
Mark Cusworth, VP of Research and Development at PRISYM ID examines the EU Medical Device Regulation and its implications on labelling
Read More
